Esther Pohl‐Rescigno

Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer

Nana Weber‐Lassalle, Julika Borde, Konstantin Weber‐Lassalle et al. · Breast Cancer Research · 2019 · 64 citations · Full text

Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer

Esther Pohl‐Rescigno, Jan Hauke, Sibylle Loibl et al. · JAMA Oncology · 2020 · 61 citations · Full text

Performance of Breast Cancer Polygenic Risk Scores in 760 Female<i>CHEK2</i>Germline Mutation Carriers

Julika Borde, Corinna Ernst, Barbara Wappenschmidt et al. · JNCI Journal of the National Cancer Institute · 2020 · 34 citations · Full text

Clonal Hematopoiesis–Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer

Konstantin Weber‐Lassalle, Corinna Ernst, Kathrin Möllenhoff et al. · JNCI Journal of the National Cancer Institute · 2021 · 33 citations · Full text

Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer

Andreas Schneeweiß, Laura L. Michel, Volker Möbus et al. · European Journal of Cancer · 2021 · 31 citations

Breast Oncology, Oncology, Pathology +6